Description
A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
This trial is available at multiple Sutter Locations. Please contact one of the following about Study NRG BR002
San Francisco: ClinicalTrials@sutterhealth.org
Palo Alto/Santa Cruz: Tanya Pozniansky pozniat@sutterhealth.org
East Bay: James Nasman NasmanJ@sutterhealth.org and Vivian Leong, RN Leongv@sutterhealth.org
Sacramento: Rodrigi@sutterhealth.org and babskik@sutterhealth.org
Modesto: MassonD@sutterhealth.org and PalosA@sutterhealth.org
Solano-Vallejo Cancer Center: gonzals@sutterhealth.org
Recruitment is currently on hold for data analysis
View study details on ClinicalTrials.gov
Principal Investigator
Oleg I. Krijanovski, M.D., Ph.D.
Recruitment Status
Active, Not Recruiting
Start Date
February 01, 2019
Related Studies
Breast Cancer Chemoprevention in Primary Care at Geisinger
Investigators: External PI, Principal Investigator, Xiaowei (Sherry) Yan, PhD, MS